Global Point-of-Care Testing (POCT) Sales Market Report 2023

Publisher Name :
Date: 02-Jan-2023
No. of pages: 145
Inquire Before Buying

Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

Market Analysis and Insights: Global Point-of-Care Testing (POCT) Market

Due to the COVID-19 pandemic, the global Point-of-Care Testing (POCT) market size is estimated to be worth US$ 25670 million in 2022 and is forecast to a readjusted size of US$ 48500 million by 2029 with a CAGR of 9.4% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Blood Glucose Testing accounting for % of the Point-of-Care Testing (POCT) global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Clinics segment is altered to an % CAGR throughout this forecast period.

Global Point-of-Care Testing (POCT) main players are Roche, Abbott, Johnson & Johnson, etc. Global top three manufacturers hold a share over 45%. North America is the largest market, with a share nearly 40%.

Global Point-of-Care Testing (POCT) Scope and Market Size

The global Point-of-Care Testing (POCT) market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Point-of-Care Testing (POCT) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.

Segment by Type

- Blood Glucose Testing

- Infectious Diseases Testing

- Cardiac Markers Testing

- Coagulation Testing

- Pregnancy and Fertility Testing

- Blood Gas/Electrolytes Testing

- Urinalysis Testing

Segment by Application

- Clinics

- Hospitals

- Laboratory

- Others

By Region

- United States

- Europe

- China

- Japan

- Southeast Asia

- India

- Other Regions

By Company

- Roche

- Abbott

- Johnson & Johnson

- Siemens Healthcare

- Danaher

- Ascensia

- Bio-Rad Laboratories

- BioMerieux

- ARKRAY

- Nova Biomedical

- Trividia Health

- Quidel

- Accriva

- OraSure Technologies

- Helena Laboratories

- A. Menarini Diagnostics

- Abaxis (Zoetis)

- Ortho Clinical Diagnostics

- Phamatech

- Chembio Diagnostics

- Trinity Biotech

- ELITech Group

- Response Biomedical

- Princeton BioMeditech

- Alfa Wassermann

Global Point-of-Care Testing (POCT) Sales Market Report 2023

Table of Contents
1 Point-of-Care Testing (POCT) Market Overview
1.1 Point-of-Care Testing (POCT) Product Scope
1.2 Point-of-Care Testing (POCT) Segment by Type
1.2.1 Global Point-of-Care Testing (POCT) Sales by Type (2018 & 2022 & 2029)
1.2.2 Blood Glucose Testing
1.2.3 Infectious Diseases Testing
1.2.4 Cardiac Markers Testing
1.2.5 Coagulation Testing
1.2.6 Pregnancy and Fertility Testing
1.2.7 Blood Gas/Electrolytes Testing
1.2.8 Urinalysis Testing
1.3 Point-of-Care Testing (POCT) Segment by Application
1.3.1 Global Point-of-Care Testing (POCT) Sales Comparison by Application (2018 & 2022 & 2029)
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Laboratory
1.3.5 Others
1.4 Point-of-Care Testing (POCT) Market Estimates and Forecasts (2018-2029)
1.4.1 Global Point-of-Care Testing (POCT) Market Size in Value Growth Rate (2018-2029)
1.4.2 Global Point-of-Care Testing (POCT) Market Size in Volume Growth Rate (2018-2029)
1.4.3 Global Point-of-Care Testing (POCT) Price Trends (2018-2029)
2 Point-of-Care Testing (POCT) Estimates and Forecasts by Region
2.1 Global Point-of-Care Testing (POCT) Market Size by Region: 2018 VS 2022 VS 2029
2.2 Global Point-of-Care Testing (POCT) Retrospective Market Scenario by Region (2018-2023)
2.2.1 Global Point-of-Care Testing (POCT) Sales Market Share by Region (2018-2023)
2.2.2 Global Point-of-Care Testing (POCT) Revenue Market Share by Region (2018-2023)
2.3 Global Point-of-Care Testing (POCT) Market Estimates and Forecasts by Region (2024-2029)
2.3.1 Global Point-of-Care Testing (POCT) Sales Estimates and Forecasts by Region (2024-2029)
2.3.2 Global Point-of-Care Testing (POCT) Revenue Forecast by Region (2024-2029)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Point-of-Care Testing (POCT) Estimates and Projections (2018-2029)
2.4.2 Europe Point-of-Care Testing (POCT) Estimates and Projections (2018-2029)
2.4.3 China Point-of-Care Testing (POCT) Estimates and Projections (2018-2029)
2.4.4 Japan Point-of-Care Testing (POCT) Estimates and Projections (2018-2029)
2.4.5 Southeast Asia Point-of-Care Testing (POCT) Estimates and Projections (2018-2029)
2.4.6 India Point-of-Care Testing (POCT) Estimates and Projections (2018-2029)
3 Global Point-of-Care Testing (POCT) Competition Landscape by Players
3.1 Global Top Point-of-Care Testing (POCT) Players by Sales (2018-2023)
3.2 Global Top Point-of-Care Testing (POCT) Players by Revenue (2018-2023)
3.3 Global Point-of-Care Testing (POCT) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Point-of-Care Testing (POCT) as of 2022)
3.4 Global Point-of-Care Testing (POCT) Average Price by Company (2018-2023)
3.5 Manufacturers Point-of-Care Testing (POCT) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Point-of-Care Testing (POCT) Market Size by Type
4.1 Global Point-of-Care Testing (POCT) Historic Market Review by Type (2018-2023)
4.1.1 Global Point-of-Care Testing (POCT) Sales by Type (2018-2023)
4.1.2 Global Point-of-Care Testing (POCT) Revenue by Type (2018-2023)
4.1.3 Global Point-of-Care Testing (POCT) Price by Type (2018-2023)
4.2 Global Point-of-Care Testing (POCT) Market Estimates and Forecasts by Type (2024-2029)
4.2.1 Global Point-of-Care Testing (POCT) Sales Forecast by Type (2024-2029)
4.2.2 Global Point-of-Care Testing (POCT) Revenue Forecast by Type (2024-2029)
4.2.3 Global Point-of-Care Testing (POCT) Price Forecast by Type (2024-2029)
5 Global Point-of-Care Testing (POCT) Market Size by Application
5.1 Global Point-of-Care Testing (POCT) Historic Market Review by Application (2018-2023)
5.1.1 Global Point-of-Care Testing (POCT) Sales by Application (2018-2023)
5.1.2 Global Point-of-Care Testing (POCT) Revenue by Application (2018-2023)
5.1.3 Global Point-of-Care Testing (POCT) Price by Application (2018-2023)
5.2 Global Point-of-Care Testing (POCT) Market Estimates and Forecasts by Application (2024-2029)
5.2.1 Global Point-of-Care Testing (POCT) Sales Forecast by Application (2024-2029)
5.2.2 Global Point-of-Care Testing (POCT) Revenue Forecast by Application (2024-2029)
5.2.3 Global Point-of-Care Testing (POCT) Price Forecast by Application (2024-2029)
6 United States Point-of-Care Testing (POCT) Market Facts & Figures
6.1 United States Point-of-Care Testing (POCT) Sales by Company
6.1.1 United States Point-of-Care Testing (POCT) Sales by Company (2018-2023)
6.1.2 United States Point-of-Care Testing (POCT) Revenue by Company (2018-2023)
6.2 United States Point-of-Care Testing (POCT) Sales Breakdown by Type
6.2.1 United States Point-of-Care Testing (POCT) Sales Breakdown by Type (2018-2023)
6.2.2 United States Point-of-Care Testing (POCT) Sales Breakdown by Type (2024-2029)
6.3 United States Point-of-Care Testing (POCT) Sales Breakdown by Application
6.3.1 United States Point-of-Care Testing (POCT) Sales Breakdown by Application (2018-2023)
6.3.2 United States Point-of-Care Testing (POCT) Sales Breakdown by Application (2024-2029)
7 Europe Point-of-Care Testing (POCT) Market Facts & Figures
7.1 Europe Point-of-Care Testing (POCT) Sales by Company
7.1.1 Europe Point-of-Care Testing (POCT) Sales by Company (2018-2023)
7.1.2 Europe Point-of-Care Testing (POCT) Revenue by Company (2018-2023)
7.2 Europe Point-of-Care Testing (POCT) Sales Breakdown by Type
7.2.1 Europe Point-of-Care Testing (POCT) Sales Breakdown by Type (2018-2023)
7.2.2 Europe Point-of-Care Testing (POCT) Sales Breakdown by Type (2024-2029)
7.3 Europe Point-of-Care Testing (POCT) Sales Breakdown by Application
7.3.1 Europe Point-of-Care Testing (POCT) Sales Breakdown by Application (2018-2023)
7.3.2 Europe Point-of-Care Testing (POCT) Sales Breakdown by Application (2024-2029)
8 China Point-of-Care Testing (POCT) Market Facts & Figures
8.1 China Point-of-Care Testing (POCT) Sales by Company
8.1.1 China Point-of-Care Testing (POCT) Sales by Company (2018-2023)
8.1.2 China Point-of-Care Testing (POCT) Revenue by Company (2018-2023)
8.2 China Point-of-Care Testing (POCT) Sales Breakdown by Type
8.2.1 China Point-of-Care Testing (POCT) Sales Breakdown by Type (2018-2023)
8.2.2 China Point-of-Care Testing (POCT) Sales Breakdown by Type (2024-2029)
8.3 China Point-of-Care Testing (POCT) Sales Breakdown by Application
8.3.1 China Point-of-Care Testing (POCT) Sales Breakdown by Application (2018-2023)
8.3.2 China Point-of-Care Testing (POCT) Sales Breakdown by Application (2024-2029)
9 Japan Point-of-Care Testing (POCT) Market Facts & Figures
9.1 Japan Point-of-Care Testing (POCT) Sales by Company
9.1.1 Japan Point-of-Care Testing (POCT) Sales by Company (2018-2023)
9.1.2 Japan Point-of-Care Testing (POCT) Revenue by Company (2018-2023)
9.2 Japan Point-of-Care Testing (POCT) Sales Breakdown by Type
9.2.1 Japan Point-of-Care Testing (POCT) Sales Breakdown by Type (2018-2023)
9.2.2 Japan Point-of-Care Testing (POCT) Sales Breakdown by Type (2024-2029)
9.3 Japan Point-of-Care Testing (POCT) Sales Breakdown by Application
9.3.1 Japan Point-of-Care Testing (POCT) Sales Breakdown by Application (2018-2023)
9.3.2 Japan Point-of-Care Testing (POCT) Sales Breakdown by Application (2024-2029)
10 Southeast Asia Point-of-Care Testing (POCT) Market Facts & Figures
10.1 Southeast Asia Point-of-Care Testing (POCT) Sales by Company
10.1.1 Southeast Asia Point-of-Care Testing (POCT) Sales by Company (2018-2023)
10.1.2 Southeast Asia Point-of-Care Testing (POCT) Revenue by Company (2018-2023)
10.2 Southeast Asia Point-of-Care Testing (POCT) Sales Breakdown by Type
10.2.1 Southeast Asia Point-of-Care Testing (POCT) Sales Breakdown by Type (2018-2023)
10.2.2 Southeast Asia Point-of-Care Testing (POCT) Sales Breakdown by Type (2024-2029)
10.3 Southeast Asia Point-of-Care Testing (POCT) Sales Breakdown by Application
10.3.1 Southeast Asia Point-of-Care Testing (POCT) Sales Breakdown by Application (2018-2023)
10.3.2 Southeast Asia Point-of-Care Testing (POCT) Sales Breakdown by Application (2024-2029)
11 India Point-of-Care Testing (POCT) Market Facts & Figures
11.1 India Point-of-Care Testing (POCT) Sales by Company
11.1.1 India Point-of-Care Testing (POCT) Sales by Company (2018-2023)
11.1.2 India Point-of-Care Testing (POCT) Revenue by Company (2018-2023)
11.2 India Point-of-Care Testing (POCT) Sales Breakdown by Type
11.2.1 India Point-of-Care Testing (POCT) Sales Breakdown by Type (2018-2023)
11.2.2 India Point-of-Care Testing (POCT) Sales Breakdown by Type (2024-2029)
11.3 India Point-of-Care Testing (POCT) Sales Breakdown by Application
11.3.1 India Point-of-Care Testing (POCT) Sales Breakdown by Application (2018-2023)
11.3.2 India Point-of-Care Testing (POCT) Sales Breakdown by Application (2024-2029)
12 Company Profiles and Key Figures in Point-of-Care Testing (POCT) Business
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Business Overview
12.1.3 Roche Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
12.1.4 Roche Point-of-Care Testing (POCT) Products Offered
12.1.5 Roche Recent Development
12.2 Abbott
12.2.1 Abbott Corporation Information
12.2.2 Abbott Business Overview
12.2.3 Abbott Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
12.2.4 Abbott Point-of-Care Testing (POCT) Products Offered
12.2.5 Abbott Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Corporation Information
12.3.2 Johnson & Johnson Business Overview
12.3.3 Johnson & Johnson Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
12.3.4 Johnson & Johnson Point-of-Care Testing (POCT) Products Offered
12.3.5 Johnson & Johnson Recent Development
12.4 Siemens Healthcare
12.4.1 Siemens Healthcare Corporation Information
12.4.2 Siemens Healthcare Business Overview
12.4.3 Siemens Healthcare Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
12.4.4 Siemens Healthcare Point-of-Care Testing (POCT) Products Offered
12.4.5 Siemens Healthcare Recent Development
12.5 Danaher
12.5.1 Danaher Corporation Information
12.5.2 Danaher Business Overview
12.5.3 Danaher Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
12.5.4 Danaher Point-of-Care Testing (POCT) Products Offered
12.5.5 Danaher Recent Development
12.6 Ascensia
12.6.1 Ascensia Corporation Information
12.6.2 Ascensia Business Overview
12.6.3 Ascensia Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
12.6.4 Ascensia Point-of-Care Testing (POCT) Products Offered
12.6.5 Ascensia Recent Development
12.7 Bio-Rad Laboratories
12.7.1 Bio-Rad Laboratories Corporation Information
12.7.2 Bio-Rad Laboratories Business Overview
12.7.3 Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
12.7.4 Bio-Rad Laboratories Point-of-Care Testing (POCT) Products Offered
12.7.5 Bio-Rad Laboratories Recent Development
12.8 BioMerieux
12.8.1 BioMerieux Corporation Information
12.8.2 BioMerieux Business Overview
12.8.3 BioMerieux Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
12.8.4 BioMerieux Point-of-Care Testing (POCT) Products Offered
12.8.5 BioMerieux Recent Development
12.9 ARKRAY
12.9.1 ARKRAY Corporation Information
12.9.2 ARKRAY Business Overview
12.9.3 ARKRAY Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
12.9.4 ARKRAY Point-of-Care Testing (POCT) Products Offered
12.9.5 ARKRAY Recent Development
12.10 Nova Biomedical
12.10.1 Nova Biomedical Corporation Information
12.10.2 Nova Biomedical Business Overview
12.10.3 Nova Biomedical Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
12.10.4 Nova Biomedical Point-of-Care Testing (POCT) Products Offered
12.10.5 Nova Biomedical Recent Development
12.11 Trividia Health
12.11.1 Trividia Health Corporation Information
12.11.2 Trividia Health Business Overview
12.11.3 Trividia Health Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
12.11.4 Trividia Health Point-of-Care Testing (POCT) Products Offered
12.11.5 Trividia Health Recent Development
12.12 Quidel
12.12.1 Quidel Corporation Information
12.12.2 Quidel Business Overview
12.12.3 Quidel Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
12.12.4 Quidel Point-of-Care Testing (POCT) Products Offered
12.12.5 Quidel Recent Development
12.13 Accriva
12.13.1 Accriva Corporation Information
12.13.2 Accriva Business Overview
12.13.3 Accriva Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
12.13.4 Accriva Point-of-Care Testing (POCT) Products Offered
12.13.5 Accriva Recent Development
12.14 OraSure Technologies
12.14.1 OraSure Technologies Corporation Information
12.14.2 OraSure Technologies Business Overview
12.14.3 OraSure Technologies Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
12.14.4 OraSure Technologies Point-of-Care Testing (POCT) Products Offered
12.14.5 OraSure Technologies Recent Development
12.15 Helena Laboratories
12.15.1 Helena Laboratories Corporation Information
12.15.2 Helena Laboratories Business Overview
12.15.3 Helena Laboratories Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
12.15.4 Helena Laboratories Point-of-Care Testing (POCT) Products Offered
12.15.5 Helena Laboratories Recent Development
12.16 A. Menarini Diagnostics
12.16.1 A. Menarini Diagnostics Corporation Information
12.16.2 A. Menarini Diagnostics Business Overview
12.16.3 A. Menarini Diagnostics Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
12.16.4 A. Menarini Diagnostics Point-of-Care Testing (POCT) Products Offered
12.16.5 A. Menarini Diagnostics Recent Development
12.17 Abaxis (Zoetis)
12.17.1 Abaxis (Zoetis) Corporation Information
12.17.2 Abaxis (Zoetis) Business Overview
12.17.3 Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
12.17.4 Abaxis (Zoetis) Point-of-Care Testing (POCT) Products Offered
12.17.5 Abaxis (Zoetis) Recent Development
12.18 Ortho Clinical Diagnostics
12.18.1 Ortho Clinical Diagnostics Corporation Information
12.18.2 Ortho Clinical Diagnostics Business Overview
12.18.3 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
12.18.4 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Products Offered
12.18.5 Ortho Clinical Diagnostics Recent Development
12.19 Phamatech
12.19.1 Phamatech Corporation Information
12.19.2 Phamatech Business Overview
12.19.3 Phamatech Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
12.19.4 Phamatech Point-of-Care Testing (POCT) Products Offered
12.19.5 Phamatech Recent Development
12.20 Chembio Diagnostics
12.20.1 Chembio Diagnostics Corporation Information
12.20.2 Chembio Diagnostics Business Overview
12.20.3 Chembio Diagnostics Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
12.20.4 Chembio Diagnostics Point-of-Care Testing (POCT) Products Offered
12.20.5 Chembio Diagnostics Recent Development
12.21 Trinity Biotech
12.21.1 Trinity Biotech Corporation Information
12.21.2 Trinity Biotech Business Overview
12.21.3 Trinity Biotech Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
12.21.4 Trinity Biotech Point-of-Care Testing (POCT) Products Offered
12.21.5 Trinity Biotech Recent Development
12.22 ELITech Group
12.22.1 ELITech Group Corporation Information
12.22.2 ELITech Group Business Overview
12.22.3 ELITech Group Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
12.22.4 ELITech Group Point-of-Care Testing (POCT) Products Offered
12.22.5 ELITech Group Recent Development
12.23 Response Biomedical
12.23.1 Response Biomedical Corporation Information
12.23.2 Response Biomedical Business Overview
12.23.3 Response Biomedical Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
12.23.4 Response Biomedical Point-of-Care Testing (POCT) Products Offered
12.23.5 Response Biomedical Recent Development
12.24 Princeton BioMeditech
12.24.1 Princeton BioMeditech Corporation Information
12.24.2 Princeton BioMeditech Business Overview
12.24.3 Princeton BioMeditech Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
12.24.4 Princeton BioMeditech Point-of-Care Testing (POCT) Products Offered
12.24.5 Princeton BioMeditech Recent Development
12.25 Alfa Wassermann
12.25.1 Alfa Wassermann Corporation Information
12.25.2 Alfa Wassermann Business Overview
12.25.3 Alfa Wassermann Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
12.25.4 Alfa Wassermann Point-of-Care Testing (POCT) Products Offered
12.25.5 Alfa Wassermann Recent Development
13 Point-of-Care Testing (POCT) Manufacturing Cost Analysis
13.1 Point-of-Care Testing (POCT) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Point-of-Care Testing (POCT)
13.4 Point-of-Care Testing (POCT) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Point-of-Care Testing (POCT) Distributors List
14.3 Point-of-Care Testing (POCT) Customers
15 Market Dynamics
15.1 Point-of-Care Testing (POCT) Industry Trends
15.2 Point-of-Care Testing (POCT) Market Drivers
15.3 Point-of-Care Testing (POCT) Market Challenges
15.4 Point-of-Care Testing (POCT) Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Point-of-Care Testing (POCT) Sales (US$ Million) Growth Rate by Type (2018 & 2022 & 2029)
Table 2. Global Point-of-Care Testing (POCT) Sales ((US$ Million)) Comparison by Application (2018 & 2022 & 2029)
Table 3. Global Point-of-Care Testing (POCT) Market Size (US$ Million) by Region: 2018 VS 2022 VS 2029
Table 4. Global Point-of-Care Testing (POCT) Sales (M Units) by Region (2018-2023)
Table 5. Global Point-of-Care Testing (POCT) Sales Market Share by Region (2018-2023)
Table 6. Global Point-of-Care Testing (POCT) Revenue (US$ Million) Market Share by Region (2018-2023))
Table 7. Global Point-of-Care Testing (POCT) Revenue Share by Region (2018-2023)
Table 8. Global Point-of-Care Testing (POCT) Sales (M Units) Forecast by Region (2024-2029)
Table 9. Global Point-of-Care Testing (POCT) Sales Market Share Forecast by Region (2024-2029)
Table 10. Global Point-of-Care Testing (POCT) Revenue (US$ Million) Forecast by Region (2024-2029)
Table 11. Global Point-of-Care Testing (POCT) Revenue Share Forecast by Region (2024-2029)
Table 12. Global Point-of-Care Testing (POCT) Sales by Company (M Units) & (2018-2023)
Table 13. Global Point-of-Care Testing (POCT) Sales Share by Company (2018-2023)
Table 14. Global Point-of-Care Testing (POCT) Revenue by Company (US$ Million) & (2018-2023)
Table 15. Global Point-of-Care Testing (POCT) Revenue Share by Company (2018-2023)
Table 16. Global Point-of-Care Testing (POCT) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point-of-Care Testing (POCT) as of 2022)
Table 17. Global Market Point-of-Care Testing (POCT) Average Price by Company (USD/Unit) & (2018-2023)
Table 18. Manufacturers Point-of-Care Testing (POCT) Manufacturing Sites and Area Served
Table 19. Manufacturers Point-of-Care Testing (POCT) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Point-of-Care Testing (POCT) Sales by Type (2018-2023) & (M Units)
Table 22. Global Point-of-Care Testing (POCT) Sales Share by Type (2018-2023)
Table 23. Global Point-of-Care Testing (POCT) Revenue by Type (2018-2023) & (US$ Million)
Table 24. Global Point-of-Care Testing (POCT) Price by Type (2018-2023) & (USD/Unit)
Table 25. Global Point-of-Care Testing (POCT) Sales by Type (2024-2029)
Table 26. Global Point-of-Care Testing (POCT) Revenue by Type (2024-2029) & (US$ Million)
Table 27. Global Point-of-Care Testing (POCT) Revenue Share by Type (2024-2029)
Table 28. Global Point-of-Care Testing (POCT) Price by Type (2024-2029) & (USD/Unit)
Table 29. Global Point-of-Care Testing (POCT) Sales by Application (2018-2023) & (M Units)
Table 30. Global Point-of-Care Testing (POCT) Sales Share by Application (2018-2023)
Table 31. Global Point-of-Care Testing (POCT) Revenue by Application (2018-2023) & (US$ Million)
Table 32. Global Point-of-Care Testing (POCT) Price by Application (2018-2023) & (USD/Unit)
Table 33. Global Point-of-Care Testing (POCT) Sales by Application (2024-2029) & (M Units)
Table 34. Global Point-of-Care Testing (POCT) Sales Share by Application (2024-2029)
Table 35. Global Point-of-Care Testing (POCT) Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Point-of-Care Testing (POCT) Revenue Share by Application (2024-2029)
Table 37. Global Point-of-Care Testing (POCT) Price by Application (2024-2029) & (USD/Unit)
Table 38. United States Point-of-Care Testing (POCT) Sales by Company (2018-2023) & (M Units)
Table 39. United States Point-of-Care Testing (POCT) Sales Market Share by Company (2018-2023)
Table 40. United States Point-of-Care Testing (POCT) Revenue by Company (2018-2023) & (US$ Million)
Table 41. United States Point-of-Care Testing (POCT) Revenue Market Share by Company (2018-2023)
Table 42. United States Point-of-Care Testing (POCT) Sales by Type (2018-2023) & (M Units)
Table 43. United States Point-of-Care Testing (POCT) Sales Market Share by Type (2018-2023)
Table 44. United States Point-of-Care Testing (POCT) Sales by Type (2024-2029) & (M Units)
Table 45. United States Point-of-Care Testing (POCT) Sales Market Share by Type (2024-2029)
Table 46. United States Point-of-Care Testing (POCT) Sales by Application (2018-2023) & (M Units)
Table 47. United States Point-of-Care Testing (POCT) Sales Market Share by Application (2018-2023)
Table 48. United States Point-of-Care Testing (POCT) Sales by Application (2024-2029) & (M Units)
Table 49. United States Point-of-Care Testing (POCT) Sales Market Share by Application (2024-2029)
Table 50. Europe Point-of-Care Testing (POCT) Sales by Company (2018-2023) & (M Units)
Table 51. Europe Point-of-Care Testing (POCT) Sales Market Share by Company (2018-2023)
Table 52. Europe Point-of-Care Testing (POCT) Revenue by Company (2018-2023) & (US$ Million)
Table 53. Europe Point-of-Care Testing (POCT) Revenue Market Share by Company (2018-2023)
Table 54. Europe Point-of-Care Testing (POCT) Sales by Type (2018-2023) & (M Units)
Table 55. Europe Point-of-Care Testing (POCT) Sales Market Share by Type (2018-2023)
Table 56. Europe Point-of-Care Testing (POCT) Sales by Type (2024-2029) & (M Units)
Table 57. Europe Point-of-Care Testing (POCT) Sales Market Share by Type (2024-2029)
Table 58. Europe Point-of-Care Testing (POCT) Sales by Application (2018-2023) & (M Units)
Table 59. Europe Point-of-Care Testing (POCT) Sales Market Share by Application (2018-2023)
Table 60. Europe Point-of-Care Testing (POCT) Sales by Application (2024-2029) & (M Units)
Table 61. Europe Point-of-Care Testing (POCT) Sales Market Share by Application (2024-2029)
Table 62. China Point-of-Care Testing (POCT) Sales by Company (2018-2023) & (M Units)
Table 63. China Point-of-Care Testing (POCT) Sales Market Share by Company (2018-2023)
Table 64. China Point-of-Care Testing (POCT) Revenue by Company (2018-2023) & (US$ Million)
Table 65. China Point-of-Care Testing (POCT) Revenue Market Share by Company (2018-2023)
Table 66. China Point-of-Care Testing (POCT) Sales by Type (2018-2023) & (M Units)
Table 67. China Point-of-Care Testing (POCT) Sales Market Share by Type (2018-2023)
Table 68. China Point-of-Care Testing (POCT) Sales by Type (2024-2029) & (M Units)
Table 69. China Point-of-Care Testing (POCT) Sales Market Share by Type (2024-2029)
Table 70. China Point-of-Care Testing (POCT) Sales by Application (2018-2023) & (M Units)
Table 71. China Point-of-Care Testing (POCT) Sales Market Share by Application (2018-2023)
Table 72. China Point-of-Care Testing (POCT) Sales by Application (2024-2029) & (M Units)
Table 73. China Point-of-Care Testing (POCT) Sales Market Share by Application (2024-2029)
Table 74. Japan Point-of-Care Testing (POCT) Sales by Company (2018-2023) & (M Units)
Table 75. Japan Point-of-Care Testing (POCT) Sales Market Share by Company (2018-2023)
Table 76. Japan Point-of-Care Testing (POCT) Revenue by Company (2018-2023) & (US$ Million)
Table 77. Japan Point-of-Care Testing (POCT) Revenue Market Share by Company (2018-2023)
Table 78. Japan Point-of-Care Testing (POCT) Sales by Type (2018-2023) & (M Units)
Table 79. Japan Point-of-Care Testing (POCT) Sales Market Share by Type (2018-2023)
Table 80. Japan Point-of-Care Testing (POCT) Sales by Type (2024-2029) & (M Units)
Table 81. Japan Point-of-Care Testing (POCT) Sales Market Share by Type (2024-2029)
Table 82. Japan Point-of-Care Testing (POCT) Sales by Application (2018-2023) & (M Units)
Table 83. Japan Point-of-Care Testing (POCT) Sales Market Share by Application (2018-2023)
Table 84. Japan Point-of-Care Testing (POCT) Sales by Application (2024-2029) & (M Units)
Table 85. Japan Point-of-Care Testing (POCT) Sales Market Share by Application (2024-2029)
Table 86. Southeast Asia Point-of-Care Testing (POCT) Sales by Company (2018-2023) & (M Units)
Table 87. Southeast Asia Point-of-Care Testing (POCT) Sales Market Share by Company (2018-2023)
Table 88. Southeast Asia Point-of-Care Testing (POCT) Revenue by Company (2018-2023) & (US$ Million)
Table 89. Southeast Asia Point-of-Care Testing (POCT) Revenue Market Share by Company (2018-2023)
Table 90. Southeast Asia Point-of-Care Testing (POCT) Sales by Type (2018-2023) & (M Units)
Table 91. Southeast Asia Point-of-Care Testing (POCT) Sales Market Share by Type (2018-2023)
Table 92. Southeast Asia Point-of-Care Testing (POCT) Sales by Type (2024-2029) & (M Units)
Table 93. Southeast Asia Point-of-Care Testing (POCT) Sales Market Share by Type (2024-2029)
Table 94. Southeast Asia Point-of-Care Testing (POCT) Sales by Application (2018-2023) & (M Units)
Table 95. Southeast Asia Point-of-Care Testing (POCT) Sales Market Share by Application (2018-2023)
Table 96. Southeast Asia Point-of-Care Testing (POCT) Sales by Application (2024-2029) & (M Units)
Table 97. Southeast Asia Point-of-Care Testing (POCT) Sales Market Share by Application (2024-2029)
Table 98. India Point-of-Care Testing (POCT) Sales by Company (2018-2023) & (M Units)
Table 99. India Point-of-Care Testing (POCT) Sales Market Share by Company (2018-2023)
Table 100. India Point-of-Care Testing (POCT) Revenue by Company (2018-2023) & (US$ Million)
Table 101. India Point-of-Care Testing (POCT) Revenue Market Share by Company (2018-2023)
Table 102. India Point-of-Care Testing (POCT) Sales by Type (2018-2023) & (M Units)
Table 103. India Point-of-Care Testing (POCT) Sales Market Share by Type (2018-2023)
Table 104. India Point-of-Care Testing (POCT) Sales by Type (2024-2029) & (M Units)
Table 105. India Point-of-Care Testing (POCT) Sales Market Share by Type (2024-2029)
Table 106. India Point-of-Care Testing (POCT) Sales by Application (2018-2023) & (M Units)
Table 107. India Point-of-Care Testing (POCT) Sales Market Share by Application (2018-2023)
Table 108. India Point-of-Care Testing (POCT) Sales by Application (2024-2029) & (M Units)
Table 109. India Point-of-Care Testing (POCT) Sales Market Share by Application (2024-2029)
Table 110. Roche Corporation Information
Table 111. Roche Description and Business Overview
Table 112. Roche Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Roche Point-of-Care Testing (POCT) Product
Table 114. Roche Recent Development
Table 115. Abbott Corporation Information
Table 116. Abbott Description and Business Overview
Table 117. Abbott Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Abbott Point-of-Care Testing (POCT) Product
Table 119. Abbott Recent Development
Table 120. Johnson & Johnson Corporation Information
Table 121. Johnson & Johnson Description and Business Overview
Table 122. Johnson & Johnson Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Johnson & Johnson Point-of-Care Testing (POCT) Product
Table 124. Johnson & Johnson Recent Development
Table 125. Siemens Healthcare Corporation Information
Table 126. Siemens Healthcare Description and Business Overview
Table 127. Siemens Healthcare Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Siemens Healthcare Point-of-Care Testing (POCT) Product
Table 129. Siemens Healthcare Recent Development
Table 130. Danaher Corporation Information
Table 131. Danaher Description and Business Overview
Table 132. Danaher Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Danaher Point-of-Care Testing (POCT) Product
Table 134. Danaher Recent Development
Table 135. Ascensia Corporation Information
Table 136. Ascensia Description and Business Overview
Table 137. Ascensia Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Ascensia Point-of-Care Testing (POCT) Product
Table 139. Ascensia Recent Development
Table 140. Bio-Rad Laboratories Corporation Information
Table 141. Bio-Rad Laboratories Description and Business Overview
Table 142. Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Bi
  • Global Influenza Diagnostics Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 85
    Influenza is an infectious disease and affects The upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to The influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are The essential first step for laboratory detection of influenz......
  • Global Tuberculosis (TB) Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107
    According to our LPI (LP Information) latest study, the global Tuberculosis (TB) Diagnostics market size was valued at US$ 2572.8 million in 2023. With growing demand in downstream market, the Tuberculosis (TB) Diagnostics is forecast to a readjusted size of US$ 3540.9 million by 2030 with a CAGR of 4.7% during review period. The research report highlights the growth potential of the global Tuberculosis (TB) Diagnostics market. Tuberculosis (TB) Diagnostics are expected to show stable gr......
  • Global POC Diagnostics Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128
    According to our LPI (LP Information) latest study, the global POC Diagnostics market size was valued at US$ 25110 million in 2023. With growing demand in downstream market, the POC Diagnostics is forecast to a readjusted size of US$ 48170 million by 2030 with a CAGR of 9.8% during review period. The research report highlights the growth potential of the global POC Diagnostics market. POC Diagnostics are expected to show stable growth in the future market. However, product differentiatio......
  • Global Allergy Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Allergy Diagnostics market size was valued at US$ 5070.7 million in 2023. With growing demand in downstream market, the Allergy Diagnostics is forecast to a readjusted size of US$ 10550 million by 2030 with a CAGR of 11.0% during review period. The research report highlights the growth potential of the global Allergy Diagnostics market. Allergy Diagnostics are expected to show stable growth in the future market. However, prod......
  • Global Influenza Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Influenza Diagnostics market size was valued at US$ 2284.7 million in 2023. With growing demand in downstream market, the Influenza Diagnostics is forecast to a readjusted size of US$ 3558.7 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global Influenza Diagnostics market. Influenza Diagnostics are expected to show stable growth in the future market. Howev......
  • Global Tuberculosis (TB) Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 112
    According to our (Global Info Research) latest study, the global Tuberculosis (TB) Diagnostics market size was valued at USD 2706.1 million in 2023 and is forecast to a readjusted size of USD 3635.2 million by 2030 with a CAGR of 4.3% during review period. Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, i......
  • Global Influenza Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111
    According to our (Global Info Research) latest study, the global Influenza Diagnostics market size was valued at USD 2403.1 million in 2023 and is forecast to a readjusted size of USD 3620.3 million by 2030 with a CAGR of 6.0% during review period. Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus......
  • Global Point-of-Care Diagnostics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 12-Dec-2023        Price: US 3380 Onwards        Pages: 122
    Market Overview of Global Point-of-Care Diagnostics market: According to our latest research, the global Point-of-Care Diagnostics market looks promising in the next 5 years. As of 2022, the global Point-of-Care Diagnostics market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
  • Global Viral Disease Diagnosis Professional Survey Report 2023, Forecast to 2028
    Published: 27-Nov-2023        Price: US 3280 Onwards        Pages: 105
    They have been used as an alternative method of diagnosing viral diseases. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared acr......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs